Latest Breaking News On - Amicus therapeutics - Page 8 : comparemela.com

Amicus Therapeutics, Inc (NASDAQ:FOLD) Stock Position Raised by China Universal Asset Management Co Ltd

Amicus Therapeutics, Inc (NASDAQ:FOLD) Stock Position Raised by China Universal Asset Management Co Ltd
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

David michael clarkJohnf crowleyMorgan stanleyWilliam blair investment managementCantor fitzgeraldAmicus therapeutics incChina universal asset management coJpmorgan chase coSecurities exchange commissionNorges bankAmicus therapeuticsVictory capital management incChina universal asset managementFree reportUniversal asset managementBlair investment management

USFDA gives tentative approval to Lupin s drug for treatment of rare genetic disorder - Pharma News

USFDA gives tentative approval to Lupin s drug for treatment of rare genetic disorder - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United statesAmicus therapeuticsLupin limited onDrug administrationLupin limitedUnited states foodAbbreviated new drug applicationMigalastat capsulesGalafold capsules

Amicus Therapeutics (NASDAQ:FOLD) Stock Price Down 2 5%

Amicus Therapeutics (NASDAQ:FOLD) Stock Price Down 2 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Samantha proutEllen rosenbergSkyview investment advisorsSecurities exchange commissionJpmorgan chase coAmicus therapeutics incAssociates corpAmicus therapeuticsMorgan stanleyCantor fitzgeraldGet free reportTherapeutics trading downExchange commissionView investment advisorsAmicus therapeutics daily

Amicus Therapeutics (NASDAQ:FOLD) Stock Price Down 2 5%

Amicus Therapeutics (NASDAQ:FOLD) Stock Price Down 2 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandDavid michael clarkEllen rosenbergMorgan stanleySecurities exchange commissionCantor fitzgeraldAmicus therapeuticsWellington management groupVanguard group incAmicus therapeutics incJpmorgan chase coBlackrock incPerceptive advisorsGet free reportExchange commission

WuXi Biologics Reports Solid 2023 Annual Results - Thailand Business News

Revenue Increased by 11.6% Y-o-Y to RMB17,034.3 Million

United statesHong kongNordrhein westfalenPharmadule morimatsuChris chenGroup free cash flowCompany for the reporting periodBoston research service centerAmicus therapeutics incInternational society for pharmaceutical engineeringShareholders of the companyCayman incEuropean commissionThriving research business achieved remarkable successWuxi biologics cayman incTechnology platform launched to boost development strength